Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Generated Narrative: Evidence 179588
version: 6; Last updated: 2023-12-08 13:32:26+0000
Profile: NetEffectContribution
url: https://fevir.net/resources/Evidence/179588
identifier: FEvIR Object Identifier/179588
name: NetEffectContribution_Remission_of_diabetes_for_Example_for_GIN_2022
title: NetEffectContribution: Remission of diabetes for Example for GIN 2022
status: Active
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
author: Brian S. Alper:
| Code | Value[x] |
| Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | ComparativeEvidence |
| Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | NetEffectContribution |
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
| Type | Citation | ResourceReference |
| Cite As | NetEffectContribution: Remission of diabetes for Example for GIN 2022 [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179588. Revised 2023-12-06. Available at: https://fevir.net/resources/Evidence/179588. Computable resource at: https://fevir.net/resources/Evidence/179588. | |
| Amended With | Outcome Importance Rating (default value 5) of Remission of diabetes |
description:
2.15 (1.33 to 3.26) - example showing statistic.extension:modelExpression
variableDefinition
description:
Cohort study with baseline data of exposures from November 2005 through July 2010 and follow-up data from 2006 until death or through December 2015 at a tertiary care outpatient center, Vestfold Hospital Trust, Norway. Consecutive treatment-seeking adult patients (n = 2109) with severe obesity assessed (221 patients excluded and 1888 patients included).
variableRole: Population
observed: StudyGroup: Severely Obese Adults 2018 Norwegian Cohort
variableDefinition
description:
comparison groups of bariatric surgery vs. no bariatric surgery
variableRole: Exposure
comparatorCategory: no bariatric surgery
observed: GroupAssignment: Bariatric Surgery vs. no bariatric surgery
variableDefinition
description:
Remission of diabetes
variableRole: Outcome
observed: OutcomeVariable: Remission of diabetes
variableDefinition
description:
Relative Importance Multiplier
variableRole: Covariate
roleSubtype: Relative importance multiplier
observed: Relative Importance Multiplier
statistic
StatisticModelExpression:
Evidence[id='104121'].statistic[statisticType='Relative Risk'] * Evidence[id='104396'].statistic[statisticType='Proportion'] * $this.relatedArtifact[type=#amended-with].resourceReference(processOutcomeImportance)(Net effect contribution analysis"risk difference (relative risk x control event rate) multiplied by relative importance multiplier (defined in OutcomeImportance Profile) -- expression is pseudocode to demonstrate the concept")description:
risk difference 2.15 (95% CI 1.33 to 3.26)
statisticType: Risk Difference
quantity: 2.15
AttributeEstimates
Description Type Level Range 95% CI 1.33 to 3.26
confidence interval 0.95 1.33-3.26 ModelCharacteristics
Code Net effect contribution analysis
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#2.0.0-ballot based on FHIR 6.0.0-ballot2. Generated 2024-12-19
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change